Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

stirling products ltd (STI) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
A$-0.02
Shares Outstanding
2.2B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for STIRLING PRODUCTS LTD (STI)

Related News

No related news articles were found.

stirling products ltd (STI) Related Businessweek News

No Related Businessweek News Found

stirling products ltd (STI) Details

Stirling Products Limited engages in the manufacture and marketing of proprietary and/or patented pharmaceutical products and natural health products primarily in Australia and Canada. The company is developing ImmunoXel formulation, which is under clinical trials for the treatment of TB and AIDS. It provides animal products, including R-Salbutamol growth agents, which are metabolic modifiers that convert energy used for fat production into energy for meat production. The company also offers drug delivery platform comprising high density aerosol technology that is used in delivering drugs via inhalation. In addition, it focuses on offering botanical products, such as natural herbal immune supplements under the Nature's Firewall and i-Naturals brand names. Further, the company focuses on providing clinically proven naturally derived products and pharmaceuticals, as well as contract manufacturing services. Stirling Products Limited is headquartered in Sydney, Australia.

120 Employees
Last Reported Date: 09/30/10

stirling products ltd (STI) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: --
Chairman of the Board, Managing Director, Mem...
Total Annual Compensation: --
Chief Operating Officer, Executive Director o...
Total Annual Compensation: --
Member of Scientific Advisory Board and Chief...
Total Annual Compensation: --
Group Chief Executive Officer and Business De...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

stirling products ltd (STI) Key Developments

Stirling Products Ltd. Reports Cash Flow Results for the Second Quarter and Six Months Ended December 31, 2012

Stirling Products Ltd. reported cash flow results for the second quarter and six months ended December 31, 2012. For the quarter, the company reported net operating cash flows used in operating activities of AUD 2,000. For the six months period, the company reported net operating cash flows used in operating activities of AUD 10,000.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STI:AU A$0.00 AUD 0.00

STI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for STI.
View Industry Companies
 

Industry Analysis

STI

Industry Average

Valuation STI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STIRLING PRODUCTS LTD, please visit www.stirlingproducts.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.